uniQure

UniQure Stock Doubles After Striking A Deal With The FDA For Huntington's Drug
Investors Business Daily
Tue, 12/10/24 - 11:31 am
uniQure
FDA
Huntington's disease
AMT-130
Huntington’s disease R&D is regaining ground after several disappointments
Pharma Voice
Mon, 09/9/24 - 10:44 am
Huntington's disease
uniQure
Prilenia Therapeutics
Wave
Roche
Ionis Pharmaceuticals
Vico Therapeutics
UniQure Wins First FDA RMAT in Huntington’s Disease After Strong Phase I/II Data
BioSpace
Tue, 07/9/24 - 11:51 am
uniQure
AMT-130
Huntington's disease
clinical trials
UniQure, with sale of plant, outsources Hemgenix manufacturing
BioPharma Dive
Mon, 07/1/24 - 11:31 am
uniQure
gene therapy
drug manufacturing
Genezen
Hemgenix
Benefit of uniQure's Huntington's gene therapy will be revealed 'in the fullness of time'
Fierce Biotech
Tue, 12/19/23 - 11:14 pm
uniQure
Huntington's disease
gene therapy
Gene therapy maker UniQure to cut about 20% of workforce
Reuters
Thu, 10/5/23 - 10:10 am
uniQure
gene therapy
layoffs
Uniqure’s accelerated approval hopes take a hit
EP Vantage
Thu, 06/22/23 - 10:07 am
uniQure
Huntington's disease
gene therapy
AMT-130
After Hemgenix approvals, uniQure cashes out some of its royalty rights for $375M-plus
Fierce Pharma
Mon, 05/15/23 - 06:23 pm
uniQure
Hemgenix
gene therapy
hemophilia A
Major readouts on the horizon for small developers
EP Vantage
Fri, 03/31/23 - 10:19 am
Aldeyra Therapeutics
Autolus Therapeutics
Bavarian Nordic
BioXcel Therapeutics
Disc Medicine
Editas Medicine
Immunogen
Lantheus
Mersana Therapeutics
NGM Biopharmaceuticals
Omeros
Roche
Sutro BioPharma
uniQure
Valneva
Viking Therapeutics
10 clinical trials to watch in the first half of 2023
BioPharma Dive
Tue, 01/3/23 - 10:57 am
clinical trials
Alzheimer's disease
obesity
Huntington's disease
M&A
AstraZeneca
Daiichi Sankyo
Nimbus Therapeutics
Takeda
Eli Lilly
Sanofi
Regeneron
Moderna Therapeutics
Gilead Sciences
Pfizer
Roivant
Alnylam
uniQure
Big pharma’s new year catalysts
EP Vantage
Mon, 12/19/22 - 11:05 am
AstraZeneca
Daiichi Sankyo
Pfizer
Roche
CSL
uniQure
Novo Nordisk
Eli Lilly
Bristol Myers has change of heart on cardiovascular gene therapy pact, terminating uniQure deal
Fierce Biotech
Tue, 11/29/22 - 10:57 am
Bristol Myers Squibb
uniQure
gene therapy
uniQure, CSL claim first okay for hemophilia B gene therapy
Pharmaphorum
Wed, 11/23/22 - 07:53 am
uniQure
CSL
hemophila B
gene therapy
Hemgenix
FDA
UniQure revs up engines again for Huntington's gene therapy after trial hospitalizations
Fierce Biotech
Wed, 11/2/22 - 10:49 pm
uniQure
Huntington's disease
gene therapy
AMT-130
uniQure pauses part of Huntington's trial after 3 patients hospitalized—1 of whom hasn’t fully recovered
Fierce Biotech
Mon, 08/8/22 - 11:33 pm
uniQure
clinical trials
Huntington's disease
AMT-130
uniQure shares spike as investors see bright spot in 12-month Huntington's gene therapy data
Fierce Biotech
Thu, 06/23/22 - 07:51 pm
uniQure
Huntington's disease
gene therapy
AMT-130
CSL-UniQure Hemophilia B Gene Therapy Scores Priority Review
BioSpace
Tue, 05/24/22 - 04:34 pm
CSL Behring
uniQure
hemophilia B
gene therapy
FDA
priority review
etranacogene dezaparvovec
As biotech retreats, gene therapy companies retrench and redraw plans
BioPharma Dive
Thu, 03/24/22 - 08:29 pm
biotech
gene therapy
layoffs
R&D
Bluebird Bio
Allogene
uniQure
Fresh data show UniQure's hemophilia gene therapy appears to hold up
BioPharma Dive
Fri, 12/10/21 - 12:01 am
uniQure
gene therapy
hemophilia
hemophilia B
Biotech M&A tracker: After hitting new heights, deals have slowed down. Here are the latest.
BioPharma Dive
Tue, 08/10/21 - 11:12 pm
M&A
Bayer
Sanofi
Amgen
uniQure
MorphoSys
Xeris Pharmaceuticals
Relay Therapeutics
Merck
Beam Therapeutics
Jazz Pharmaceuticals

Pages